Cord Blood Transplantation for Patients With Cancer

NCT01359254 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped did not accrue enough patients.

Conditions

Hematological Disease

Interventions

DRUG: Melphalan
DRUG: Fludarabine
DRUG: Antithymocyte Globulin (ATG)
DRUG: Busulfan
DRUG: Total Body Irradiation (TBI)

Sponsor

University of Chicago